This inventor holds 1 USPTO granted patent. Top assignee: Hoffmann-La Roche Inc.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Michael Weber - Innovator in Medicinal Chemistry
Introduction
Michael Weber is a distinguished inventor based in Sissach, Switzerland. He has made significant contributions to the field of medicinal chemistry, particularly through his innovative work on HCN1 inhibitors.
Latest Patents
Michael Weber holds a patent for Alkynyl-(heteroaryl)-carboxamide HCN1 inhibitors. The present invention provides compounds of formula I wherein R, R', or R'' are as described herein, as well as pharmaceutically acceptable salts thereof. Furthermore, the invention is concerned with the manufacture of these compounds, pharmaceutical compositions comprising them, and their use as medicaments.
Career Highlights
Michael Weber is currently employed at Hoffmann-La Roche Inc., a leading global healthcare company. His work focuses on developing novel therapeutic agents that can address various medical conditions.
Collaborations
Throughout his career, Michael has collaborated with notable colleagues, including Eoin O'Connor and Jean-Yves Wach. These collaborations have further enhanced his research and development efforts in the pharmaceutical industry.
Conclusion
Michael Weber's innovative contributions to medicinal chemistry and his patent on HCN1 inhibitors highlight his role as a key figure in the advancement of pharmaceutical science. His work continues to impact the development of new therapeutic options.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile